Spectrum Health Pennock Hospital in Delton, MI - Social Worker

Spectrum Health Pennock Hospital is a mental health clinic (Social Worker - Clinical) in Delton, Michigan. The current practice location for Spectrum Health Pennock Hospital is 10425 Panther Pride, Delton, Michigan. For appointments, you can reach them via phone at (616) 775-7500. The mailing address for Spectrum Health Pennock Hospital is 100 Michigan Ne St Mc845, Grand Rapids, Michigan and phone number is (616) 486-6790.

Spectrum Health Pennock Hospital is licensed to practice in * (Not Available) (license number ) and its NPI number is 1457088080. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (616) 775-7500.

Contact Information

	Spectrum Health Pennock Hospital
	10425 Panther Pride Delton MI 49046-8825
	(616) 775-7500
	Not Available

Mental Health Clinic Profile

Full Name	Spectrum Health Pennock Hospital
Speciality	Social Worker - Clinical
Location	10425 Panther Pride, Delton, Michigan
Authorized Official Name and Position	Ryan Catignani (VP FINANCE)
Authorized Official Contact	9475220008
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Spectrum Health Pennock Hospital 100 Michigan Ne St Mc845 Grand Rapids MI 49503-2560 Ph: (616) 486-6790	Spectrum Health Pennock Hospital 10425 Panther Pride Delton MI 49046-8825 Ph: (616) 775-7500

NPI Details:

NPI Number	1457088080
Provider Enumeration Date	08/03/2022
Last Update Date	09/07/2023
Certification Date	09/07/2023

Medical Identifiers

Medical identifiers for Spectrum Health Pennock Hospital such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1457088080	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	(* (Not Available))	Primary

News Archive

Purdue and Mundipharma assume worldwide development for Infinity's fatty acid amide hydrolase program

Infinity Pharmaceuticals, Inc. today announced that Purdue Pharmaceutical Products L.P. and its independent associated company, Mundipharma International Corporation Ltd., have exercised their right to assume worldwide development and commercialization activities for Infinity's fatty acid amide hydrolase, or FAAH, program. The decision reflects progress made in the development of Infinity's oral FAAH inhibitor, IPI-940.

UMB enters license agreement with Bali BioSciences for new strategy to combat sepsis, HIV/AIDS

The University of Maryland, Baltimore's (UMB) Office of Technology Transfer has completed a license agreement with Bali BioSciences LLC, an early-stage company pursuing an unusual, yet clever, strategy to combat disease.

Dairy Council highlights milk's irreplaceable role in healthy, balanced eating patterns

Thanks to decades of scientific research, almost everyone knows that milk offers many health benefits and is an essential part of a healthy diet. Ongoing research continues to find amazing properties of milk that may surprise even the most dedicated milk drinker.

"Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads" report from MarketResearch.com

MarketResearch.com has announced the addition of Kalorama Information's new report "Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads," to their collection of In Vitro Diagnostics market reports.

More than 15% of school children have a developmental disability

More than 15 percent of school-age kids — about 10 million children — had a developmental disability in 2006-08, according to a study released Monday in the journal Pediatrics.

Spectrum Health Pennock Hospital - Mental Health Clinic in Delton, MI